ConductScience.org, home
Papers
API referenceFor AI assistants

Paper3262015

Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.

Somasundaram R and 2 others. Cancer Immunol Immunother, 1988. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells. Papers, record 3262015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3262015

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2024-04-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Somasundaram RR
2Advani SHS H
3Gangal SGS G

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, MyeloidMajor topic
T-Lymphocytes, CytotoxicMajor topic
Antigens, Differentiation, T-Lymphocyte
Bone Marrow
Clone Cells
Humans
Interleukin-2
Phenotype

Source PubMed

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,232,114Human T-cell growth factor (TCGF).Crit Rev Immunol1984https://conductscience.org/library/papers/6232114PubMed
2308,961Cytotoxic activities of normal cultured human T cells.J Immunol1978https://conductscience.org/library/papers/308961PubMed
33,493,226Production of stable cytolytic T-cell clones directed against autologous human melanoma.Int J Cancer1987https://conductscience.org/library/papers/3493226PubMed
4145,543Long term culture of tumour-specific cytotoxic T cells.Nature1977https://conductscience.org/library/papers/145543PubMed
53,523,804The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.Springer Semin Immunopathol1986https://conductscience.org/library/papers/3523804PubMed
66,197,458Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.J Immunol1984https://conductscience.org/library/papers/6197458PubMed
7181,845Selective in vitro growth of T lymphocytes from normal human bone marrows.Science1976https://conductscience.org/library/papers/181845PubMed
83,158,614Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.Int J Cancer1985https://conductscience.org/library/papers/3158614PubMed
96,790,607A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).J Immunol1981https://conductscience.org/library/papers/6790607PubMed
106,607,099Adoptive autoimmunotherapy. Cytotoxic effect of an autologous long-term T-cell line on malignant melanoma.Cancer1984https://conductscience.org/library/papers/6607099PubMed
113,875,569Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.Int J Cancer1985https://conductscience.org/library/papers/3875569PubMed
122,578,402Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3.Eur J Immunol1985https://conductscience.org/library/papers/2578402PubMed
132,961,214Cell surface molecules and early events involved in human T lymphocyte activation.Adv Immunol1987https://conductscience.org/library/papers/2961214PubMed
14307,029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
156,225,511Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6225511PubMed
16224,318Continuous culture of T cells cytotoxic for autologous human leukaemia cells.Nature1979https://conductscience.org/library/papers/224318PubMed
173,491,673Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.Cancer Res1987https://conductscience.org/library/papers/3491673PubMed
186,977,725Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells.Nature1982https://conductscience.org/library/papers/6977725PubMed
196,450,603In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.Br J Cancer1981https://conductscience.org/library/papers/6450603PubMed
206,980,492Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.Surgery1982https://conductscience.org/library/papers/6980492PubMed

See all 25 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
2,526,681Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2526681PubMed
2,289,201Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2289201PubMed
1,902,397
Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.
Cancer Immunol Immunother1991https://conductscience.org/library/papers/1902397PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B3GAT127,087PubTator's text mininghttps://conductscience.org/library/genes/27087NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HLA-C3,107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IL23,558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3262015

GET https://conductscience.org/api/papers/v1/3262015/references?page=2

API referenceFor AI assistants